Although the methylation of SOX1 have been found to be associated with genitourinary tumors, including cervical cancer, prostate cancer and ovarian cancer, this is the first time that methylation of SOX1 has been found in NSCLC (6–8). Here, SOX1 is linked to prostate cancer.